Convulxin (CVX), a C-type lectin-like protein isolated from the venom of the snake species, Crotalus durissus terrificus, stimulates platelet aggregation by acting as a collagen receptor agonist for glycoprotein VI found in the platelets. The effect of CVX on platelets has been studied, but its effect on human peripheral blood mononuclear cells (PBMCs) remains unclear. Given the significance of PBMCs in inflammation, this study explored the effect of CVX on PBMCs, specifically regarding NLRP3 inflammasome activation by assessing cell viability, ability to induce cell proliferation, reactive oxygen species (ROS) and nitric oxide production, interleukin (IL)-2 and IL-10 secretion, NLRP3 complex activation, and the role of C-type lectin-like receptors (CTLRs) in these. CVX was not toxic to PBMCs at the investigated concentrations and did not increase PBMC growth or IL-2 release; however, CVX induced IL-10 release and ROS generation via monocyte activation. It also activated the NLRP3 complex, resulting in IL-1β induction. Furthermore, the interaction between CVX and Dectin-2, a CTLR, induced IL-10 production. CVX interaction with CTLR has been demonstrated by laminarin therapy. Because of the involvement of residues near the Dectin-2 carbohydrate-recognition site, the generation of ROS resulted in inflammasome activation and IL-1β secretion. Overall, this work helps elucidate the function of CVX in immune system cells.
Background:
Several studies have aimed to identify molecules that inhibit the toxic actions
of snake venom phospholipases A2 (PLA2s). Studies carried out with PLA2 inhibitors (PLIs) have been
shown to be efficient in this assignment.
Objective:
This work aimed to analyze the interaction of peptides derived from Bothrops atrox PLIγ
(atPLIγ) with a PLA2 and to evaluate the ability of these peptides to reduce phospholipase and myotoxic
activities.
Methods:
Peptides were subjected to molecular docking with a homologous Lys49 PLA2 from B. atrox
venom modeled by homology. Phospholipase activity neutralization assay was performed with BthTX-II
and different ratios of the peptides. A catalytically active and an inactive PLA2 were purified from the B.
atrox venom and used together in the in vitro myotoxic activity neutralization experiments with the peptides.
Results:
The peptides interacted with amino acids near the PLA2 hydrophobic channel and the loop that
would be bound to calcium in Asp49 PLA2. They were able to reduce phospholipase activity and peptides
DFCHNV and ATHEE reached the highest reduction levels, being these two peptides the best that
also interacted in the in silico experiments. The peptides reduced the myotubes cell damage with a highlight
for the DFCHNV peptide, which reduced by about 65%. It has been suggested that myotoxic activity
reduction is related to the sites occupied in the PLA2 structure, which could corroborate the results
observed in molecular docking.
Conclusion:
This study should contribute to the investigation of the potential of PLIs to inhibit the toxic
effects of PLA2s.
In order to address the global antivenom crisis, novel antivenoms need to present high therapeutic efficacy, broad neutralization ability against systemic and local damage, sufficient safety, and cost-effectiveness. Due to biological characteristics of camelid single-domain antibodies (VHH) such as high affinity, their ability to penetrate dense tissues, and facility for genetic manipulation, their application in antivenoms has expanded considerably. VHHs that are active against the metalloprotease BjussuMP-II from the snake Bothrops jararacussu were selected. After isolation of BjussuMP-II, a camelid was immunized with the purified toxin in order to construct the recombinant phage library. Following a round of biopanning, 52% of the selected clones were able to recognize BjussuMP-II in an ELISA assay. After sequencing, seven sequence profiles were identified. One selected clone (VHH61) showed cross-reactivity to B. brazili venom, but did not recognize the Crotalus and Lachesis genera, indicating specificity for the Bothrops genus. Through in vitro tests, the capacity to neutralize the toxicity triggered by BjussuMP-II was observed. Circular dichroism spectroscopy indicated a robust secondary structure for VHH61, and the calculated melting temperature (
T
M
) for the clone was 56.4°C. In silico analysis, through molecular docking of anti-BjussuMP-II VHHs with metalloprotease, revealed their potential interaction with amino acids present in regions critical for the toxin’s conformation and stability. The findings suggest that anti-BjussuMP-II VHHs may be beneficial in the development of next-generation antivenoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.